NovoCure (NVCR) Assets Average (2015 - 2026)
NovoCure (NVCR) posted Assets Average of $791.6 million for Q2 2026, down 0.57% sequentially from $796.1 million in Q1 2026, and down 36.54% YoY from $1.2 billion in Q2 2025.
NovoCure (NVCR) Assets Average (2015 - 2026) Analysis & Trends
NovoCure has reported Assets Average for 12 years, with the latest figure at $791.6 million in Q2 2026.
- Quarterly Assets Average fell 36.54% year-over-year to $791.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $791.6 million (down 36.54% YoY) and the FY2025 annual result came in at $1.0 billion, down 14.32% from the prior year.
- Assets Average declined to $791.6 million in Q2 2026 per NVCR's latest filing, from $796.1 million in the prior quarter.
- Over five years, Assets Average peaked at $1.3 billion in Q3 2025 and troughed at $791.6 million in Q2 2026.
- A 5-year average of $1.1 billion and a median of $1.2 billion in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average gained 9.79% in 2025, then plunged 36.54% in 2026.
- Over 5 years, Assets Average stood at $1.2 billion in 2022, then decreased by 3.1% to $1.1 billion in 2023, then rose by 7.43% to $1.2 billion in 2024, then decreased by 12.07% to $1.1 billion in 2025, then decreased by 26.89% to $791.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $791.6 million, $796.1 million, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 10.74 Bn |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn | 791.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 791.56 Mn |
| Mar 31, 2026 | 796.13 Mn |
| Dec 31, 2025 | 1.08 Bn |
| Sep 30, 2025 | 1.30 Bn |
| Jun 30, 2025 | 1.25 Bn |
| Mar 31, 2025 | 1.24 Bn |
| Dec 31, 2024 | 1.23 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.17 Bn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.18 Bn |
| Sep 30, 2022 | 1.17 Bn |
| Jun 30, 2022 | 1.16 Bn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 1.13 Bn |
| Sep 30, 2021 | 1.11 Bn |